December 9, 2014 | The premature infant and child formula company Nutrinia announced that it raised $12 million from Pontifax, OrbiMed and the Jacobs family, according to a “Globes” report. The company has discovered that by delivering insulin to the intestine makes maturation possible, improving the absorption of nutrients. According to the company’s trials, its product can potentially shorten the duration of infant intravenous feeding by up to 4-9 days, shortening their hospital visit by up to 7 days. The company will use the funds for two Phase III clinical trials of its product that are set to begin in 2015. Nutrinia was founded by Prof. Naim Shehadeh at Rambam Medical Center in Haifa and is part of the NGT incubator in Nazareth.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Non-Profit Launches 10M Shekel Fund For Israeli Small Businesses
December 06, 2023

Amid War, Program Helps Open US Doors For 10 Israeli Startups
December 06, 2023

Israeli Data Privacy Startup Raises $30M in Wartime
December 05, 2023

Israel Awards ‘World’s First’ License For Drone Flights
December 05, 2023
Facebook comments